Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.

about

In-Hospital Surgery as a Risk Factor for Onset of AmpC-Producing Blood Stream Infections

P2860

Q58804183-0F7093BD-91F2-4195-A9B9-E7F7CCB4E469

P2860

Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.

Item

http://www.wikidata.org/entity/Q40567310

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Bloodstream infections caused ...... miology and clinical features.

@en

type

Item

label

Bloodstream infections caused ...... miology and clinical features.

@en

prefLabel

Bloodstream infections caused ...... miology and clinical features.

@en

P1476

Bloodstream infections caused ...... emiology and clinical features

@en

P2093

A Rivera

http://www.w3.org/2001/XMLSchema#string

G Ortiz

http://www.w3.org/2001/XMLSchema#string

J Pérez

http://www.w3.org/2001/XMLSchema#string

M A Morera

http://www.w3.org/2001/XMLSchema#string

M C Garcia

http://www.w3.org/2001/XMLSchema#string

M Gurguí

http://www.w3.org/2001/XMLSchema#string

M Simó

http://www.w3.org/2001/XMLSchema#string

N Alonso

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular epidemiology of extended-spectrum β-lactamase-, AmpC β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolated from Canadian hospitals over a 5 year period: CANWARD 2007-11

A new method of classifying prognostic comorbidity in longitudinal studies: development and validation

The epidemiology of sepsis in the United States from 1979 through 2000

Major differences exist in frequencies of virulence factors and multidrug resistance between community and nosocomial Escherichia coli bloodstream isolates

Laboratory surveillance for prospective plasmid-mediated AmpC beta-lactamases in the Kinki region of Japan

Microbiologic and clinical implications of bacteremia due to extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae with or without plasmid-mediated AmpC beta-lactamase DHA-1.

Virulence profiles of bacteremic extended-spectrum β-lactamase-producing Escherichia coli: association with epidemiological and clinical features

The worldwide emergence of plasmid-mediated quinolone resistance.

The changing epidemiology of resistance.

CTX-M: changing the face of ESBLs in Europe.

P2888

s10096-016-2752-3

P304

1997-2003

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S10096-016-2752-3

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Mónica Rodríguez Carballeira

Mariona Xercavins

V Pascual

P577

2016-08-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1031367408

http://www.w3.org/2001/XMLSchema#string

P698

27549108

http://www.w3.org/2001/XMLSchema#string

Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.

about

P2860

P2860

Bloodstream infections caused by Escherichia coli producing AmpC β-lactamases: epidemiology and clinical features.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698